RECRUITING

Evaluation and Further Development of an Artificial Intelligence-based Algorithm for Clinical Decision Support

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Invasive mechanical ventilation is one of the most important and life-saving therapies in the intensive care unit (ICU). In most severe cases, extracorporeal lung support is initiated when mechanical ventilation is insufficient. However, mechanical ventilation is recognised as potentially harmful, because inappropriate mechanical ventilation settings in ICU patients are associated with organ damage, contributing to disease burden. Studies revealed that mechanical ventilation is often not provided adequately despite clear evidence and guidelines. Variables at the ventilator and extracorporeal lung support device can be set automatically using optimization functions and clinical recommendations, but the handling of experts may still deviate from those settings depending upon the clinical characteristics of individual patients. Artificial intelligence can be used to learn from those deviations as well as the patient's condition in an attempt to improve the combination of settings and accomplish lung support with reduced risk of damage.

Official Title

Retrospective Use of Patient Treatment Data for the Evaluation and Further Development of an Artificial Intelligence-based Algorithm for Clinical Decision Support in Invasive Mechanical Ventilation of Intensive Care Patients

Quick Facts

Study Start:2023-01-01
Study Completion:2025-02-28
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05668637

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Jakob Wittenstein, MD
CONTACT
+49 351 458 19887
jakob.wittenstein@ukdd.de
Thea Koch, PhD
CONTACT
thea.koch@ukdd.de

Principal Investigator

Jakob Wittenstein, MD
PRINCIPAL_INVESTIGATOR
University Hospital Carl Gustav Carus at Technischen Universität Dresden, Germany

Study Locations (Sites)

Cleveland Clinic Foundation, Cleveland, USA
Cleveland, Ohio, 44195
United States

Collaborators and Investigators

Sponsor: Technische Universität Dresden

  • Jakob Wittenstein, MD, PRINCIPAL_INVESTIGATOR, University Hospital Carl Gustav Carus at Technischen Universität Dresden, Germany

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-01-01
Study Completion Date2025-02-28

Study Record Updates

Study Start Date2023-01-01
Study Completion Date2025-02-28

Terms related to this study

Keywords Provided by Researchers

  • Mechanical ventilation
  • ventilator-induced lung injury
  • ARDS
  • artificial intelligence

Additional Relevant MeSH Terms

  • Invasive Mechanical Ventilation